Sumitomo Mitsui Trust Group, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in GILD
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$408,525,803
+$7,274,383 QoQ
Shares Held
2,931,232
-10.3% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Sumitomo Mitsui Trust Group, Inc. holds $6,316,336,395 across 9 Drug Manufacturers - General names. GILD ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,775,707 | $1,633,242,027 | |
| 2 | JNJ |
Johnson & Johnson
|
5,660,660 | $1,383,691,730 | |
| 3 | ABBV |
AbbVie Inc.
|
3,914,633 | $851,393,531 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,269,316 | $754,136,021 | |
| 5 | AMGN |
Amgen Inc
|
1,537,964 | $541,132,633 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,931,232 | $408,525,803 | |
| 7 | PFE |
Pfizer Inc
|
14,366,414 | $403,408,905 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,542,241 | $275,486,916 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $408,525,803 | 2,931,232 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $401,251,420 | 3,269,117 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $369,576,942 | 3,329,522 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $366,124,892 | 3,302,290 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $346,368,175 | 3,091,193 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $280,256,122 | 3,034,060 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $253,530,818 | 3,023,984 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $203,644,291 | 2,968,143 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $255,254,421 | 3,484,702 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $281,467,948 | 3,474,484 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $256,066,008 | 3,416,947 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $266,191,841 | 3,453,897 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $322,655,727 | 3,888,824 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $364,994,365 | 4,251,536 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $277,394,822 | 4,496,593 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $276,940,570 | 4,480,514 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $268,418,711 | 4,515,033 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $328,439,644 | 4,523,339 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $275,182,596 | 3,939,622 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $284,765,709 | 4,135,430 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $311,309,977 | 4,816,803 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $294,920,625 | 5,062,146 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $359,914,126 | 5,695,745 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $441,544,733 | 5,738,819 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $393,622,015 | 5,265,142 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||